Symbicort (budesonide/formoterol) will be used more for COPD

Symbicort (budesonide/formoterol) will be used more for COPD.

It's now the second corticosteroid/beta-agonist combo approved for maintenance of COPD...along with Advair (fluticasone/salmeterol).

But these are NOT first-line therapies.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote